Inhibitory effects of costunolide isolated from laurus nobilis on IgE-induced degranulation of mast cell-like RBL-2H3 cells and the growth of Y16 pro-B cells

Phytotherapy Research

Volumn 25, Issue 9, 2011, Pages 1392-1397

  Kim, Tae Joon ^a   Nam, Kung Woo ^a   Kim, Bora ^a   Lee, Sung Jin ^b   Oh, Ki Bong ^a   Kim, Kyeong Ho ^b   Mar, Woongchon ^a   Shin, Jongheon ^a  

^a Seoul National University   (South Korea)

^b Kangwon National University   (South Korea)

Author keywords

hexosaminidase; costunolide; interleukin 4; Laurus nobilis; RBL 2H3 cells; Y16 cells

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE; COSTULONIDE; HERBACEOUS AGENT; IMMUNOGLOBULIN E; INTERLEUKIN 4; INTERLEUKIN 5; KETOTIFEN; UNCLASSIFIED DRUG; COSTUNOLIDE; SESQUITERPENE;

ALLERGIC REACTION; ANGIOSPERM; ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BASOPHIL; CELL GROWTH; CELL LINE; CELL STRAIN RBL 2H3; CELL STRAIN Y16 PRO B CELL; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME RELEASE; ISOLATION PROCEDURE; LAURUS; LAURUS NOBILIS; MAST CELL DEGRANULATION; NONHUMAN; PLANT LEAF; PROLYMPHOCYTE; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; CHEMISTRY; DEGRANULATION; DOSE RESPONSE; DRUG EFFECTS; IC50; MAST CELL; METABOLISM; PHYSIOLOGY; PRE B LYMPHOCYTE; TUMOR CELL LINE;

LAURACEAE; LAURUS NOBILIS; RATTUS;

ANIMALS; BETA-N-ACETYLHEXOSAMINIDASES; CELL DEGRANULATION; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNOGLOBULIN E; INHIBITORY CONCENTRATION 50; INTERLEUKIN-4; INTERLEUKIN-5; LAURUS; MAST CELLS; PRECURSOR CELLS, B-LYMPHOID; RATS; SESQUITERPENES;

EID: 80052278228     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3553     Document Type: Article

References (44)

1. Aalberse RC,. 2006. Structural features of allergenic molecules. Chem Immunol Allergy 91: 134-146. (Pubitemid 43097202)
2. Aifeng L, Ailing S, Renmin L,. 2005. Preparative isolation and purification of costunolide and dehydrocostuslactone from Aucklandia lappa Decne by high-speed counter-current chromatography. J Chromatogr A 1076: 193-197.
3. Allakhverdi Z, Allam M, Renzi PM,. 2002. Inhibition of antigen-induced eosinophilia and airway hyperresponsiveness by antisense oligonucleotides directed against the common beta chain of IL-3, IL-5, GM-CSF receptors in a rat model of allergic asthma. Am J Respir Crit Care Med 165: 1015-1021. (Pubitemid 34774674)
4. Bornehag CG, Sundell J, Weschler CJ, et al,. 2004. The association between asthma and allergic symptoms in children and phthalates in house dust: a nested case-control study. Environ Health Perspect 112: 1393-1397. (Pubitemid 39386556)
5. Bouaziz A, Romera-Castillo C, Salido S, et al,. 2007. Cinnamtannin B-1 from bay wood exhibits antiapoptotic effects in human platelets. Apoptosis 12: 489-498.
6. Byeon SE, Choi WS, Hong EK, et al,. 2009. Inhibitory effect of saponin fraction from Codonopsis lanceolata on immune cell-mediated inflammatory responses. Arch Pharm Res 32: 813-822.
7. Choi IY, Kim SJ, Jeong HJ, et al,. 2007. Hesperidin inhibits expression of hypoxia inducible factor-1 alpha and inflammatory cytokine production from mast cells. Mol Cell Biochem 305: 153-161.
8. Dall'Acqua S, Viola G, Giorgetti M, Loi MC, Innocenti G,. 2006. Two new sesquiterpene lactones from the leaves of Laurus nobilis. Chem Pharm Bull (Tokyo) 54: 1187-1189. (Pubitemid 44166413)
9. De-Marino S, Borbone N, Zollo F, Ianaro A, Di-Meglio P, Iorizzi M,. 2004. Megastigmane and phenolic components from Laurus nobilis L. leaves and their inhibitory effects on nitric oxide production. J Agric Food Chem 52: 7525-7531.
10. De-Marino S, Borbone N, Zollo F, Ianaro A, Di-Meglio P, Iorizzi M,. 2005. New sesquiterpene lactones from Laurus nobilis leaves as inhibitors of nitric oxide production. Planta Med 71: 706-710. (Pubitemid 41306188)
11. Etzel RA,. 2003. How environmental exposures influence the development and exacerbation of asthma. Pediatrics 112: 233-239. (Pubitemid 36792917)
12. Fairweather D, Frisancho-Kiss S,. 2008. Mast cells and inflammatory heart disease: potential drug targets. Cardiovasc Hematol Disord Drug Targets 8: 80-90.
13. Ference JD, Last AR,. 2009. Choosing topical corticosteroids. Am Fam Physician 79: 135-140.
14. Goulden V, Wilkinson SM,. 1998. Patch testing for Compositae allergy. Br J Dermatol 138: 1018-1021. (Pubitemid 28293969)
15. Hamelmann E, Wahn U, Gelfand EW,. 1999. Role of the Th2 cytokines in the development of allergen-induced airway inflammation and hyperresponsiveness. Int Arch Allergy Immunol 118: 90-94. (Pubitemid 29195475)
16. Han EH, Park JH, Kim JY, Chung YC, Jeong HG,. 2009. Inhibitory mechanism of saponins derived from roots of Platycodon grandiflorum on anaphylactic reaction and IgE-mediated allergic response in mast cells. Food Chem Toxicol 47: 1069-1075.
17. Hibasami H, Yamada Y, Moteki H, et al,. 2003. Sesquiterpenes (costunolide and zaluzanin D) isolated from laurel (Laurus nobilis L.) induce cell death and morphological change indicative of apoptotic chromatin condensation in leukemia HL-60 cells. Int J Mol Med 12: 147-151.
18. Hoek KL, Cassell GH, Duffy LB, Atkinson TP,. 2002. Mycoplasma pneumonia induced activation and cytokine production in rodent mast cells. J Allergy Clin Immunol 109: 470-476. (Pubitemid 34234198)
19. Holgate S, Smith N, Massanari M, Jimenez P,. 2009. Effects of omalizumab on markers of inflammation in patients with allergic asthma. Allergy 64: 1728-1736.
20. Kassuya CA, Cremoneze A, Barros LF, et al,. 2009. Antipyretic and anti-inflammatory properties of the ethanolic extract, dichloromethane fraction and costunolide from Magnolia ovata (Magnoliaceae). J Ethnopharmacol 124: 369-376.
21. Le-Buanec H, Paturance S, Couillin I, et al,. 2007. Control of allergic reactions in mice by an active anti-murine IL-4 immunization. Vaccine 25: 7206-7216. (Pubitemid 47470094)
22. 2. Molecules 13: 1702-1711.
23. Metcalfe DD, Baram D, Mekori YA,. 1997. Mast cells. Physiol Rev 77: 1033-1079. (Pubitemid 27459579)
24. Pae HO, Jeong GS, Kim HS, et al,. 2007. Costunolide inhibits production of tumor necrosis factor-alpha and interleukin-6 by inducing heme oxygenase-1 in RAW264.7 macrophages. Inflamm Res 56: 520-526.
25. Pandey MM, Rastogi S, Rawat AK,. 2007. Saussurea costus: botanical, chemical and pharmacological review of an ayurvedic medicinal plant. J Ethnopharmacol 110: 379-390. (Pubitemid 46386372)
26. Pariser D., 2009. Topical corticosteroids and topical calcineurin inhibitors in the treatment of atopic dermatitis focus on percutaneous absorption. Am J Ther 16: 264-273.
27. Passante E, Ehrhardt C, Sheridan H, Frankish N,. 2009. RBL-2H3 cells are an imprecise model for mast cell mediator release. Inflamm Res 58: 611-618.
28. Passante E, Frankish N,. 2009. The RBL-2H3 cell line: its provenance and suitability as a model for the mast cell. Inflamm Res 58: 737-745.
29. Paulsen E, Andersen KE,. 2010. Screening for Compositae sensitization with pure allergens: implications of molecular structure, strength of reaction, and time of testing. Contact Dermatitis 64: 96-103.
30. Paulsen E, Andersen KE, Hausen BM,. 2001. Sensitization and cross-reaction patterns in Danish Compositae-allergic patients. Contact Dermatitis 45: 197-204. (Pubitemid 32955014)
31. Pazdrak K, Olszewska-Pazdrak B, Stafford S, Garofalo RP, Alam R,. 1998. Lyn, Jak2, and Raf-1 kinases are critical for the antiapoptotic effect of interleukin 5, whereas only Raf-1 kinase is essential for eosinophil activation and degranulation. J Exp Med 188: 421-429. (Pubitemid 28369132)
32. Pearlman DS,. 1999. Pathophysiology of the inflammatory response. J Allergy Clin Immunol 104: S132-S137. (Pubitemid 30249318)
33. Ricci M, Matucci A, Rossi O,. 1997. Source of IL-4 able to induce the development of TH2-like cells. Clin Exp Allergy 27: 488-500. (Pubitemid 27241646)
34. Rönmark E, Bjerg A, Perzanowski M, Platts-Mills T, Lundbäck B,. 2009. Major increase in allergic sensitization in schoolchildren from 1996 to 2006 in northern Sweden. J Allergy Clin Immunol 124: 357-363.
35. Saeki H., 2009. The brief commentary on guidelines for the management of atopic dermatitis 2009-the point of drug treatment. Arerugi 58: 1568-1573.
36. Schwartz LB, Austen KF,. 1980. Enzymes of the mast cell granule. J Invest Dermatol 74: 349-353. (Pubitemid 10034235)
37. Siraganian RP,. 2003. Mast cell signal transduction from the high-affinity IgE receptor. Curr Opin Immunol 15: 639-646. (Pubitemid 37434071)
38. Steinke JW, Borish L,. 2001. Th2 cytokines and asthma. Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists. Respir Res 2: 66-70. (Pubitemid 34187909)
39. Stone KD, Prussin C, Metcalfe DD,. 2010. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 125: S73-S80.
40. Sur R, Hall J, Cavender D, Malaviya R,. 2009. Role of Janus kinase-2 in IgE receptor mediated leukotriene C4 production by mast cells. Biochem Biophys Res Commun 390: 786-790.
41. Yalcin H, Anik M, Sanda MA, Cakir A,. 2007. Gas chromatography/mass spectrometry analysis of Laurus nobilis essential oil composition of northern Cyprus. J Med Food 10: 715-719.
42. Yang W, Chen J, Zhou L,. 2009. Effects of shear stress on intracellular calcium change and histamine release in rat basophilic leukemia (RBL-2H3) cells. J Environ Pathol Toxicol Oncol 28: 223-230.
43. Yoshikawa M, Shimoda H, Uemura T, Morikawa T, Kawahara Y, Matsuda H,. 2000. Alcohol absorption inhibitors from bay leaf (Laurus nobilis): structure-requirements of sesquiterpenes for the activity. Bioorg Med Chem 8: 2071-2077. (Pubitemid 30612498)
44. Zietkowski Z, Skiepko R, Tomasiak-Lozowska MM, Mroczko B, Szmitkowski M, Bodzenta-Lukaszyk A,. 2010. Changes in high-sensitivity C-reactive protein in serum and exhaled breath condensate after intensive exercise in patients with allergic asthma. Int Arch Allergy Immunol 153: 75-85.